Does Macrobid treat Aerococcus?
•
4 min read
According to a prospective observational study published in 2018, nitrofurantoin, the active ingredient in Macrobid, demonstrated a clinical and microbiological success rate of 71-76% in treating uncomplicated urinary tract infections (UTIs) caused by *Aerococcus urinae*. This makes it a valid first-line option for certain *Aerococcus* infections, though its effectiveness is influenced by the specific species and infection severity.